Surveillance for Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: Can We Be More Proactive?

Overview

Journal Frontline Gastroenterol

Specialty Gastroenterology

Date 2023 Feb 23

PMID 36818795

Authors

Dermot Gleeson

Martine Walmsley

Palak J Trivedi

Deepak Joshi

Ben Rea

Affiliations

Soon will be listed here.

Citing Articles

Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study.

Arechederra M, Bik E, Rojo C, Elurbide J, Elizalde M, Kruk B Liver Int. 2025; 45(4):e70049.

PMID: 40029142 PMC: 11874897. DOI: 10.1111/liv.70049.

References

Singhi A, Nikiforova M, Chennat J, Papachristou G, Khalid A, Rabinovitz M . Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut. 2019; 69(1):52-61. PMC: 6943248. DOI: 10.1136/gutjnl-2018-317817. View

Ali A, Tabibian J, Nasser-Ghodsi N, Lennon R, DeLeon T, Borad M . Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology. 2017; 67(6):2338-2351. DOI: 10.1002/hep.29730. View

Trivedi P, Crothers H, Mytton J, Bosch S, Iqbal T, Ferguson J . Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age. Gastroenterology. 2020; 159(3):915-928. DOI: 10.1053/j.gastro.2020.05.049. View

Chapman R, Fevery J, Kalloo A, Nagorney D, Boberg K, Shneider B . Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010; 51(2):660-78. DOI: 10.1002/hep.23294. View

Negron M, Kaplan G, Barkema H, Eksteen B, Clement F, Manns B . Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation. Inflamm Bowel Dis. 2014; 20(11):2046-55. DOI: 10.1097/MIB.0000000000000181. View

Wannhoff A, Brune M, Knierim J, Weiss K, Rupp C, Gotthardt D . Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis. Aliment Pharmacol Ther. 2019; 49(6):769-778. DOI: 10.1111/apt.15146. View

Vedeld H, Folseraas T, Lind G . Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers. JHEP Rep. 2020; 2(5):100143. PMC: 7479288. DOI: 10.1016/j.jhepr.2020.100143. View

Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A . Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002; 36(3):321-7. DOI: 10.1016/s0168-8278(01)00288-4. View

Charatcharoenwitthaya P, Enders F, Halling K, Lindor K . Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008; 48(4):1106-17. DOI: 10.1002/hep.22441. View

10.

Sorensen J, Nielsen O, Andersson M, Ainsworth M, Ytting H, Belard E . Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011. Liver Int. 2017; 38(3):532-541. DOI: 10.1111/liv.13548. View

11.

Poustchi H, Farrell G, Strasser S, Lee A, McCaughan G, George J . Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?. Hepatology. 2011; 54(6):1998-2004. DOI: 10.1002/hep.24581. View

12.

Chapman M, Thorburn D, Hirschfield G, Webster G, Rushbrook S, Alexander G . British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019; 68(8):1356-1378. PMC: 6691863. DOI: 10.1136/gutjnl-2018-317993. View

13.

Fevery J, Henckaerts L, Oirbeek R, Vermeire S, Rutgeerts P, Nevens F . Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study. Liver Int. 2011; 32(2):214-22. DOI: 10.1111/j.1478-3231.2011.02575.x. View

14.

Kim S, An J, Lim Y, Han S, Lee J, Byun J . MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma. JAMA Oncol. 2016; 3(4):456-463. PMC: 5470420. DOI: 10.1001/jamaoncol.2016.3147. View

15.

Weismuller T, Trivedi P, Bergquist A, Imam M, Lenzen H, Ponsioen C . Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology. 2017; 152(8):1975-1984.e8. PMC: 5546611. DOI: 10.1053/j.gastro.2017.02.038. View

16.

Bowlus C, Lim J, Lindor K . AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review. Clin Gastroenterol Hepatol. 2019; 17(12):2416-2422. DOI: 10.1016/j.cgh.2019.07.011. View

17.

Barner-Rasmussen N, Pukkala E, Jussila A, Farkkila M . Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland. Scand J Gastroenterol. 2020; 55(1):74-81. DOI: 10.1080/00365521.2019.1707277. View

18.

Ranieri V, Kennedy E, Walmsley M, Thorburn D, McKay K . The Primary Sclerosing Cholangitis (PSC) Wellbeing Study: Understanding psychological distress in those living with PSC and those who support them. PLoS One. 2020; 15(7):e0234624. PMC: 7337345. DOI: 10.1371/journal.pone.0234624. View

19.

Gulani V, Calamante F, Shellock F, Kanal E, Reeder S . Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017; 16(7):564-570. DOI: 10.1016/S1474-4422(17)30158-8. View

20.

Song J, Li Y, Bowlus C, Yang G, Leung P, Gershwin M . Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review. Clin Rev Allergy Immunol. 2019; 58(1):134-149. DOI: 10.1007/s12016-019-08764-7. View